Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients

Novel anti-myeloma agents have improved patient response rates, which are historically based on reductions of the M-protein. These methods can be inaccurate for quantifying M-proteins at low concentrations. We compared the consistency and clinical impact of response assignment by electrophoretic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Michallet, M, Chapuis-Cellier, C, Dejoie, T, Lombard, C, Caillon, H, Sobh, M, Moreau, P, Attal, M, Avet-Loiseau, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808078/
https://www.ncbi.nlm.nih.gov/pubmed/28663581
http://dx.doi.org/10.1038/leu.2017.209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808078/
https://www.ncbi.nlm.nih.gov/pubmed/28663581
http://dx.doi.org/10.1038/leu.2017.209

Ejemplares similares